Frazier Lifesciences Acquisition's accounts payable is $940K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2022), FLAC shows a accounts payable of $940K. That compares with $45K in the prior-year period — up 1997.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, FLAC's accounts payable is now $940K (was $45K) — a 1997.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Frazier Lifesciences Acquisition is outperforming or lagging.
Tracking FLAC's accounts payable over time shows whether Frazier Lifesciences Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $940K That compares with $45K in the prior-year period — up 1997.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this accounts payable page, Stockcircle has Frazier Lifesciences Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $940K) with ownership activity and broader fundamentals.